breakthroughs
- A finding at the La Jolla Institute for Allergy & Immunology has major implications for the development of a first-ever vaccine against dengue virus. Sujan Shresta, Ph.D, led the research team. Learn More
- A discovery by scientists has entered pharmaceutical research for use in the creation of a potential new antibody therapy for ulcerative colitis and Crohn's disease. Learn More
- Discovery of an enzyme's previously unknown role as a tumor suppressor that may be important in myeloproliferative diseases and some types of lymphoma and leukemia. Toshiaki Kawakami, M.D., Ph.D., led the research team. Learn More
- More Breakthroughs
research
- Center for Infectious Disease - dengue virus, smallpox, hepatitis C, and emerging biothreats like SARS and more.
- Type 1 Diabetes Center - accelerating the path to find a safe prevention and cure for type 1 (juvenile) diabetes.
- Allergy & Asthma - controlling life-altering or life-threatening reactions.
- Autoimmune Diseases - diabetes, inflammatory bowel disease, rheumatoid arthritis and more.
- Cancer Research - lymphomas & leukemias, apoptosis & cell death, stimulating immune responses against tumors and more.
- Inflammation Biology - coronary artery disease and lung disease.
- Microbiology and Immunology - inextricably linked in the study of infectious diseases.
seminars and events
- *** Summer Break ***
- Bridget Wilson, "TBD", Wednesday, 09/01/10: 12:00 PM
- View all seminars and conferences
news
- 7/20/2010 - News Release & Media Coverage
La Jolla Institute Teams with Dana-Farber and Washington University on Sickle Cell Clinical Trial
News Release link - 6/29/2010 - News Release & Media Coverage
La Jolla Institute Elects Broadcom's John Major as Board Chairman
News Release link - 6/24/2010 - UCSD-TV
Taking Control of Your Diabetes: Diabetes Prevention
Matthias von Herrath, M.D. Interview
Video page - More News
- Information on The La Jolla Institute
